Toll-like Receptor 7 Agonists in People Living with HIV: Implications for Immunotherapeutic Strategies for an HIV Cure

Grants

Funding Acknowledgements

This work was supported by the National Health and Medical Research Council (program grant and practitioner fellowship) to S. R. L., the Australian Centre for HIV and hepatitis (ACH2) to S. R. L. and T. A. R., and the National Institutes for Health (UM1AI126611) to S. R. L.